Table 4.
Multivariate analysis of recurrence-free survival and overall survival for patients with minor components of different subtypes of lung adenocarcinoma
| Subtype | OR | 95 % CI | p value |
|---|---|---|---|
| Recurrence-free survival | |||
| Lepidic | 1.361 | 0.905–2.041 | 0.139 |
| Acinar | 1.104 | 0.83–1.453 | 0.485 |
| Papillary | 0.978 | 0.752–1.271 | 0.866 |
| Micropapillary | 0.524 | 0.388–0.708 | <0.001 |
| Solid | 0.728 | 0.567–0.936 | 0.014 |
| Invasive mucinous carcinoma | 1.351 | 0.883–2.066 | 0.165 |
| Overall survival | |||
| Lepidic | 1.730 | 0.878–3.413 | 0.113 |
| Acinar | 1.122 | 0.754–1.669 | 0.571 |
| Papillary | 1.284 | 0.861–1.912 | 0.220 |
| Micropapillary | 0.585 | 0.385–0.890 | 0.012 |
| Solid | 0.690 | 0.484–0.982 | 0.039 |
| Invasive mucinous carcinoma | 0.870 | 0.519–1.456 | 0.594 |
Multivariate Cox model was adjusted for sex, age, smoking status, lymphovascular invasion or no lymphovascular invasion, tumor location, and nodal status (N0, N1, or N2). A two-tailed p < 0.05 was regarded as statistically different
OR odds ratio, CI confidence interval